Imexhs Ltd · ASX:IME
Imexhs — Microcap Conference (October 2019)
23 slides from Imexhs's conference presentation, Oct 23, 2019
Slide 1: ImExHS Corporate Presentation: Leading Medical Imaging Solutions
For personal use only ImExHS Limited – (ASX: IME) CORPORATE PRESENTATION Leading Medical Imaging Solutions October 2019 1 /
Slide 2: Overview
Overview ▪ IME founded in 2012 ▪ 2018 For personal use only ▪ Two neuroradiologists and two engineers ▪ ASX Listing ▪ Established next generation Radiology and ▪ A$6m revenue Imaging Software platform. ▪ 2019 ▪ Ongoing expansion into neighbouring LATAM countries with low risk go-to-market strategy.
Slide 3: Geographic Expansion
Geographic Expansion TOTAL DISTRIBUTION AGREEMENTS: 22 For personal use only TOTAL COUNTRIES OPERATING: 15 UNITED STATES OF AMERICA (1) HONDURAS (1) MEXICO (5) NICARAGUA (1) EL SALVADOR (1) PANAMA (1) COSTA RICA (1) COLOMBIA (3) AUSTRALIA (1) ECUADOR (1) PERU (2) BRAZIL (1) PARAGUAY BOLIVIA (1) URUA
Slide 4: Company Highlights
For personal use only Company Highlights AUD$6.0 MILLION TOTAL FY 31 Dec 2018 REVENUE > 600 Radiologists 37.5% more > 227 Customers distributors DISTRIBUTION > 87 Hospitals > 189 Clinics than 2018 > 35,000 Devices > 5m studies pa 22 distribution agreements in 15 countries. More than More than 50% 27
Slide 5: What We Do
For personal use only What We Do ImExHS owns software platform HIRUKO Scan Scheduled via HIRUKO Uploaded to HIRUKO Platform Archived on HIRUKO cloud-based platform Manages Billing } 1) Business Intelligence 2) Statistical Data 4. Referring Physician 5. Billing 1. Physician requests 2. Patient receiv
Slide 6: Hiruko
Hiruko HIRUKO® For personal use only The integral solution for your medical institution Hiruko is developed in native HTML5 code, allowing the intuitive use of RIS functionalities without sacrificing performance, wherever the physician is located. The intuitive tool for end-to-end radiological workf
Slide 7: IMEXHS Portfolio
For personal use only IMEXHS PORTFOLIO 7
Slide 8: IMEXHS is at the centre of global megatrends
IMEXHS is at the centre of global megatrends For personal use only 01 Artificial Intelligence & Machine Learning 04 Cloud, Storage Computing, ❑ Creativity is the key to success ❑ Total Mobility ❑ Development of algorithms ❑ Advances in Storage, Transmission ❑ Clean database of images and Compression
Slide 9: Award Winning Software
For personal use only Award Winning Software ➢ First place in the ➢ Finalists in awards CEEI European Union 2014 to leading 2019 Awards for business technology model. development companies. 9 ➢ Fedesoft Awards: ➢ First Place on the Digital Transformation recognition for IT Awards in the category hea
Slide 10: Success Stories
For personal use only Success Stories 1010 /
Slide 11: Business Model
For personal use only Business Model Revenue Target Distribution Target Contract Models Markets Model Geographies DIRECT SALES LATAM HEALTH CARE FACILITIES — (Now) — Global growth developing Private Hospitals & Clinics 1. Software as a Service (SaaS) branches in major markets 3-5-7 year contacts (pa
Slide 12: Company Growth
Company Growth Total Contract Value Annualised Recurring Revenue only MILLIONS 25 8 MILLIONS use 7 20 6 For personal 15 5 A$ A$ 4 10 3 2 5 1 - - 2013-06 2014-06 2015-06 2016-06 2017-06 2018-06 2019-06 2019-09 2013-06 2014-06 2015-06 2016-06 2017-06 2018-06 2019-06 2019-09 ARR ARR Not Billing 1212 /
Slide 13: LATAM Pipeline TCV (Weighted)
LATAM Pipeline TCV (Weighted) For personal use only 1313 /
Slide 14: Market Opportunity
Market Opportunity The global RIS/PACS market are collectively is expected to reach US$5b in 2027 from US$2.7b in For personal use only 2018 with the market growing at a CAGR of 7.4% during 2019-2027 EXPANSION ❑ Sales force ❑ CE clearance ❑ Anvisa Clearance ❑ Sales force ❑ Engineers & ❑ Soft launch
Slide 15: Summary & Outlook
Summary & Outlook Expansion: • USA • Australia 1 For personal use only • Brazil • Spain Increased proportion of the value chain through AI: Low touch deployment • Machine Learning model for small clinics “Multitenancy” 6 2 • Computed Vision • Neural Networks • Natural Language IMEXHS’s outlook is Pr
Slide 16: Disclaimer
For personal use only Disclaimer The information contained in this Presentation or subsequently provided to the Recipient of this Presentation, whether orally or in writing by or on behalf of ImExHS Limited or its respective employees, agents or consultants (“Information”) is provided to the Recipie
Slide 17: Thank You
Thank You imeXHS JUMPING AHEAD
Slide 18: Our History at a Glance
Our History at a Glance • Turnover of $6m AUD. • IMEXHS™ is a publicly • Turnover of listed Australian A$2m. company ASX. For personal use only • Brand • Launch of • Total contract value of registration of Hiruko ™ RIS $19.8m AUD. Hiruko ™. v2.7: Billing • Agreement of • Hiruko ™ v. 2.0 module and d
Slide 19: Customer Success Stories
Customer Success Stories DISPLACEMENT OF A MAJOR COMPETITOR We replaced an existing operating system, for 60% of the value of the monthly service fee that Customer: Clinica Las Americas the clinic was paying and no down payment. For personal use only 25 Modalities (including One of the top 23 380 co
Slide 20: Customer Success Stories
Customer Success Stories From X-ray to a fully featured digital Transition from analogue to digital PaaS solution workflow for the same monthly fee. For personal use only Customer: CAFAM IMEXHS has implemented a fully Operates 6 centres and is featured digital PaaS solution for what 600,000 members
Slide 21: Customer Success Stories
Customer Success Stories Improvements in workflow and productivity Improved Radiologist interpretation Customer: Colsubsidio time from 10 days down to 2. For personal use only KEY FACTS QUANTITATIVE IMPROVEMENTS • #1 compensation fund in the country. 19 integrated Fully integrated and • >2 million a
Slide 22: Corporate Snapshot
Corporate Snapshot 12 Month Share 12 Month Share Price Performance 12 Month Share Price Performance Price Performance For personal use only Market Price (as at 11 Oct 19) $0.043 Market Capitalisation $40.7m Shares on Issue: 925.7m Tradeable Shares 395.7m Escrowed (12-24m) 530m Options (various ex pr
Slide 23: Public Company – Trading Comparables
For personal use only Public Company – Trading Comparables VOLPARA PRO MEDICUS IMEXHS MACH7 (ASX:VHT) (ASX:PME) (ASX:IME) (ASX:M7T) Breast X-ray imaging, Radiology imaging software, Radiology imaging software, Description transitioning to SaaS based strong 5 year contracted High growth SaaS PACS sof